BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 10190893)

  • 21. TRANCE is a TNF family member that regulates dendritic cell and osteoclast function.
    Wong BR; Josien R; Choi Y
    J Leukoc Biol; 1999 Jun; 65(6):715-24. PubMed ID: 10380891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential requirements of T cell subsets for CD40 costimulation in immunity to Blastomyces dermatitidis.
    Wüthrich M; Fisette PL; Filutowicz HI; Klein BS
    J Immunol; 2006 May; 176(9):5538-47. PubMed ID: 16622023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells.
    Wong BR; Rho J; Arron J; Robinson E; Orlinick J; Chao M; Kalachikov S; Cayani E; Bartlett FS; Frankel WN; Lee SY; Choi Y
    J Biol Chem; 1997 Oct; 272(40):25190-4. PubMed ID: 9312132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD28, TNF receptor, and IL-12 are critical for CD4-independent cross-priming of therapeutic antitumor CD8+ T cells.
    Hu HM; Winter H; Ma J; Croft M; Urba WJ; Fox BA
    J Immunol; 2002 Nov; 169(9):4897-904. PubMed ID: 12391201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.
    Schoenberger SP; Toes RE; van der Voort EI; Offringa R; Melief CJ
    Nature; 1998 Jun; 393(6684):480-3. PubMed ID: 9624005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TRANCE together with IL-7 induces pre-B cells to proliferate.
    Kato I; Sato H; Kudo A
    Eur J Immunol; 2003 Feb; 33(2):334-41. PubMed ID: 12548564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-CD40 Antibody Fused to CD40 Ligand Is a Superagonist Platform for Adjuvant Intrinsic DC-Targeting Vaccines.
    Ceglia V; Zurawski S; Montes M; Kroll M; Bouteau A; Wang Z; Ellis J; Igyártó BZ; Lévy Y; Zurawski G
    Front Immunol; 2021; 12():786144. PubMed ID: 35095862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased CD40 ligand induction in CD4 T cells and dysregulated IL-12 production during HIV infection.
    Vanham G; Penne L; Devalck J; Kestens L; Colebunders R; Bosmans E; Thielemans K; Ceuppens JL
    Clin Exp Immunol; 1999 Aug; 117(2):335-42. PubMed ID: 10444266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD40 ligand is pivotal to efficient control of virus replication in mice infected with lymphocytic choriomeningitis virus.
    Thomsen AR; Nansen A; Christensen JP; Andreasen SO; Marker O
    J Immunol; 1998 Nov; 161(9):4583-90. PubMed ID: 9794385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD40-CD40 ligand interaction between dendritic cells and CD8+ T cells is needed to stimulate maximal T cell responses in the absence of CD4+ T cell help.
    Hernandez MG; Shen L; Rock KL
    J Immunol; 2007 Mar; 178(5):2844-52. PubMed ID: 17312128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor.
    Wong BR; Josien R; Lee SY; Sauter B; Li HL; Steinman RM; Choi Y
    J Exp Med; 1997 Dec; 186(12):2075-80. PubMed ID: 9396779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Murine Fibroblastic Reticular Cells From Lymph Node Interact With CD4+ T Cells Through CD40-CD40L.
    Nakayama Y; Brinkman CC; Bromberg JS
    Transplantation; 2015 Aug; 99(8):1561-7. PubMed ID: 25856408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colitis induced by enteric bacterial antigen-specific CD4+ T cells requires CD40-CD40 ligand interactions for a sustained increase in mucosal IL-12.
    Cong Y; Weaver CT; Lazenby A; Elson CO
    J Immunol; 2000 Aug; 165(4):2173-82. PubMed ID: 10925304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD40-CD40L cross-talk drives fascin expression in dendritic cells for efficient antigen presentation to CD4+ T cells.
    Elizondo DM; Andargie TE; Kubhar DS; Gugssa A; Lipscomb MW
    Int Immunol; 2017 Mar; 29(3):121-131. PubMed ID: 28369442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of CD70 on dendritic cells through CD40 or TLR stimulation contributes to the development of CD8+ T cell responses in the absence of CD4+ T cells.
    Bullock TN; Yagita H
    J Immunol; 2005 Jan; 174(2):710-7. PubMed ID: 15634890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD70 expression by dendritic cells plays a critical role in the immunogenicity of CD40-independent, CD4+ T cell-dependent, licensed CD8+ T cell responses.
    Van Deusen KE; Rajapakse R; Bullock TN
    J Leukoc Biol; 2010 Mar; 87(3):477-85. PubMed ID: 19952354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-level IL-12 production by human dendritic cells requires two signals.
    Snijders A; Kalinski P; Hilkens CM; Kapsenberg ML
    Int Immunol; 1998 Nov; 10(11):1593-8. PubMed ID: 9846688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Th2-dependent B cell responses in the absence of CD40-CD40 ligand interactions.
    Chirmule N; Tazelaar J; Wilson JM
    J Immunol; 2000 Jan; 164(1):248-55. PubMed ID: 10605018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Engaging the CD40-CD40L pathway augments T-helper cell responses and improves control of Mycobacterium tuberculosis infection.
    Sia JK; Bizzell E; Madan-Lala R; Rengarajan J
    PLoS Pathog; 2017 Aug; 13(8):e1006530. PubMed ID: 28767735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. OX40 ligand-transduced tumor cell vaccine synergizes with GM-CSF and requires CD40-Apc signaling to boost the host T cell antitumor response.
    Gri G; Gallo E; Di Carlo E; Musiani P; Colombo MP
    J Immunol; 2003 Jan; 170(1):99-106. PubMed ID: 12496388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.